CMS Approves Clover Health’s Expansion Plans for 2022
Expansion marks Clover’s entry into Alabama and nearly doubles company’s geographic footprint based on number of countiesNASHVILLE, Tenn., Sept. 22,...
News
CinFina Pharma In-Licenses Obesity Portfolio
Four novel, once-weekly anorectic agents targeting significant weight lossCINCINNATI, Sept. 22, 2021 (GLOBE NEWSWIRE) -- CinFina Pharma, LLC. (“CinFina”) announced...
XIL Health’s VP of Client Growth & Innovation Recognized as an OBJ 2021 Power Player for Industry Disruption
Alexandra Robertson’s passion to innovate Orlando’s healthcare industry and support women growing into leadership roles lands her a coveted spot...
Akari Therapeutics to Present at the Cantor Virtual Global Healthcare Conference
NEW YORK and LONDON, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biopharmaceutical company focused...
MedCAD Launches Personalized Case Tracking Web App “MyMedCAD”
DALLAS, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Increasing Case Visibility and Control In time for the official launch of AccuPlate...
BriaCell Announces TSXV Acceptance of Normal Course Issuer Bid
BERKELEY, Calif. and VANCOUVER, British Columbia, Sept. 22, 2021 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX-V: BCT)...
Odyssey Group International Begins Enrolling Subjects for Phase 1 Clinical Trial to Treat Concussion
IRVINE, CA, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTC:ODYY) (the "Company" or "Odyssey"), a medical company...
Nova Leap Health Corp. Announces Participation at the Lytham Partners Fall 2021 Investor Conference
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Sept. 22, 2021 (GLOBE NEWSWIRE)...
Healthy Extracts Begins New Clinical Trial to Investigate Ability of UBN RELIEF™ to Naturally Alleviate Migraine Symptoms and Improve Cognitive Function
UBN RELIEF™ UBN RELIEF™ is clinically proven to provide some relief from symptoms often related to migraine headaches. LAS VEGAS,...
SCYNEXIS Announces U.S. Availability of BREXAFEMME® (ibrexafungerp tablets), the First New Antifungal Class of Therapy Approved by the U.S. FDA for Vaginal Yeast Infections in More Than 20 Years
BREXAFEMME® (ibrexafungerp tablets) Product Image #1 BREXAFEMME® (ibrexafungerp tablets) Package Image #2 BREXAFEMME® (ibrexafungerp tablets) Product Logo SCYNEXIS Logo SCYNEXIS...
Checkpoint Therapeutics to Participate in the 2021 Cantor Virtual Global Healthcare Conference
WALTHAM, Mass., Sept. 22, 2021 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology...
PDS Biotechnology to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference
FLORHAM PARK, N.J., Sept. 22, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel...
Halberd and heliosDX of RushNet Enter Scientific Collaboration Agreement
Agreement To Advance Healthcare Diagnostic TechnologiesJackson Center, Pennsylvania--(Newsfile Corp. - September 22, 2021) - Halberd Corp. (OTC Pink: HALB) and...
Spyder Cannabis to Distribute RELX Vape Products
RELX closed-pod products to be offered across 180 Smoke's retail, e-commerce and wholesale channelsVaughan, Ontario--(Newsfile Corp. - September 22, 2021)...
Psyched Wellness Announces Inclusion in AdvisorShares Psychedelics Exchange Traded Fund (ETF)
Toronto, Ontario--(Newsfile Corp. - September 22, 2021) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or...
NeonMind Strengthens its Specialty Clinics Advisory Board with Appointment of Mood Disorders and Ketamine Expert Dr. Gustavo Vazquez, MD, PhD.
Company Continues to Expand Its Scientific Expertise with Noted Expert in Utilizing Ketamine for Treatment Resistant DepressionVANCOUVER, BC / ACCESSWIRE...
AlzeCure Presents at Naventus Life Science Summit on September 29
STOCKHOLM, SE / ACCESSWIRE / September 22, 2021 / AlzeCure Pharma (STO:ALZCUR) (FRA:AC6)AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical...
Sharps Technology Welcomes Robert Hayes to the Sharps Leadership Team
NEW YORK, NY / ACCESSWIRE / September 21, 2021 / Sharps Technology, an innovative medical device company offering patented, best...
Biotricity to Discuss Expansion of Remote Monitoring Medical Device Products at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on September 22nd
Biokit is the Expansion of the Company's Bioflux Cardiac-Diagnostic OfferingKits on Track for Launch in Early 2022REDWOOD CITY, CA /...
New Tech Start-Up Imaging Panda Revolutionizes Medical Imaging for Patients and Physicians in L.A.
New technology service offers patients a new way to get medical imaging and save 65 percent on x-ray, MRI, and...